Introduction.- Epidemiology, risk factors, and pathophysiology.-The clinical consultation.- Management strategies.- Palliative care in COPD.- The future of COPD.-
Richard EK Russell, FRCP, PhD, is Honorary Clinical Senior Lecturer
at Imperial College, London, UK. He trained at Guy’s Hospital and
then further in Respiratory Medicine in South London and the Royal
Brompton Hospitals. He has been a Consultant at Wexham Park and
Windsor Hospitals for 4 years with special interests in chronic
obstructive pulmonary disease (COPD), particularly its
pathophysiology, asthma and delivery of care across the
primary/secondary care interface. Dr Russell completed a PhD as a
British Lung Foundation Research Fellow. The primary area of
research was into basic mechanisms of COPD and disease progression
in smokers in primary care. This is a continuing area of study for
Dr Russell. He is active in the British Thoracic Society and the
British Lung Foundation. Dr Russell is the lead from secondary care
on the primary care quality outcomes framework national working
party.
Paul A Ford, MRCP, PhD, is MRC Senior Clinical Research Fellow at
Imperial College and Honorary Clinical Fellow at the Royal
Brompton, and Wexham and Heatherwood NHS trusts. Dr Ford qualified
from St. George’s Hospital Medical School, London, in 1990 and
completed his PhD in 2003 in Cellular Biology at Imperial College
and Royal Brompton NHS trust. His thesis was primarily concerned
with the role of the macrophage in airway inflammation,
particularly COPD. Currently, he is working on developing novel
pharmacological therapies for the treatment of COPD; in particular,
modulating airway inflammation.
Peter J Barnes, FMedSci, FRS, is Professor of Thoracic Medicine at
Imperial College London, UK. Prof. Barnes runs a large and active
multidisciplinary group of over 80 researchers exploring the
mechanisms and treatment of asthma and more recently COPD. He has
linked molecular and cell biology to clinical studies in order to
understand the inflammatory process in airway disease and to
understand the mechanisms of action of currently used drugs. He has
also pioneered the use of noninvasive markers to monitor lung
inflammation, which has enabled research into inflammatory
mechanisms to be extended to patients with severe disease. Prof.
Barnes has published over 1000 papers in peer-reviewed journals and
has written, edited or co-edited over 30 books on airway diseases
and lung pharmacology. He serves on the editorial boards of more
than 20 international journals and on several national and
international advisory boards, and is a member of the scientific
committees for the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) and Global Initiative for Asthma (GINA)
guidelines.
Sarah Russell qualified as a Nurse at Guys and Lewisham NHS Trust
in 1989 and has worked in the primary, secondary and palliative
care charity sector as a palliative care clinical nurse specialist,
team leader and multi professional educator. Sarah has a particular
interest in education, communication skills, advance careplanning
and palliative care of Chronic Obstructive Pulmonary Disease. Sarah
is currently completing a 6 year part time Doctorate in Health
Research involving a narrative video research methodology regarding
advance care planning titled ‘What would influence patients to
discuss their preferences and wishes about care at the end of
life’.
|
Ask a Question About this Product More... |
|
